Mitokondriyal Sağlık İçin En İyi Peptitler: SS-31, MOTS-c, NAD+

Summary

Mitochondrial peptides are compounds that either target mitochondrial function directly or are encoded by mitochondrial DNA itself. Three have emerged as the most researched options for cellular energy, metabolic health, and longevity: SS-31 (elamipretide), MOTS-c, and NAD+.

The Three Peptides

• SS-31 is a synthetic tetrapeptide that binds cardiolipin in the inner mitochondrial membrane, preventing lipid peroxidation and optimizing the electron transport chain. It has Phase II/III clinical trial data for heart failure and mitochondrial disease
• MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA. It activates AMPK through the folate-AICAR pathway, improving insulin sensitivity by approximately 30% in animal models (Lee et al., Cell Metabolism, 2015)
• NAD+ is a coenzyme (not technically a peptide) present in every cell. Levels decline roughly 50% between ages 40 and 60. Direct supplementation restores mitochondrial function, activates sirtuins, and supports DNA repair through PARP activation

Why 2026

• The FDA reclassification of 14 peptides to Category 1 (February 2026) includes several compounds in this space
• SS-31 Phase III data from the Barth Syndrome trial (40mg daily, 48 weeks) showed trends toward cardiac improvement
• MOTS-c research has expanded from metabolic studies into neuroprotection and pancreatic islet cell senescence (Nature, 2025)
• A fourth peptide, Humanin, discovered in the brain of an Alzheimer’s patient, is gaining attention for neuroprotection

Browse all mitochondrial peptides | Compare SS-31 vs MOTS-c

Your Mitochondria Are Declining. That’s the Problem.

Most conversations about aging focus on hormones, telomeres, or inflammation. They’re downstream effects. The upstream driver is mitochondrial dysfunction.

A single cell contains hundreds to thousands of mitochondria. They produce roughly 90% of your body’s ATP. When they stop working efficiently, energy production drops, reactive oxygen species accumulate, and cellular repair mechanisms falter. The result looks like aging: fatigue, cognitive decline, reduced exercise capacity, metabolic dysfunction.

Mitochondrial function declines measurably with age. NAD+ levels drop by roughly 50% between age 40 and 60. Cardiolipin oxidation increases. The electron transport chain becomes less efficient. This isn’t speculation. It’s measurable in blood work.

The three peptides in this guide target different parts of this decline. SS-31 stabilises the inner membrane. MOTS-c activates metabolic stress responses. NAD+ replenishes the coenzyme that every mitochondrial process depends on. Different entry points, same goal: keep the powerhouses running.

SS-31: The Membrane Stabiliser

SS-31 (also called elamipretide or Bendavia) is a synthetic aromatic-cationic tetrapeptide. It doesn’t come from mitochondrial DNA. It was designed in a lab specifically to reach the inner mitochondrial membrane.

The mechanism is unusually precise. SS-31 binds to cardiolipin, a phospholipid found exclusively in the inner mitochondrial membrane. Cardiolipin is essential for the proper functioning of cytochrome c oxidase and other electron transport chain complexes. When cardiolipin oxidises (which happens increasingly with age), the electron transport chain loses efficiency, ATP production drops, and reactive oxygen species leak out.

SS-31 prevents that oxidation. It stabilises cardiolipin, restores electron transport chain efficiency, and reduces mitochondrial ROS. A 2020 study in aged mice showed 8 weeks of SS-31 reversed age-related muscle decline, increased ATP production, and reduced oxidative stress markers.

Clinical Trials

SS-31 has the strongest clinical pipeline of any mitochondrial peptide. The key studies:

• Primary Mitochondrial Myopathy Phase II (2018): 36 patients, 40mg daily for 12 weeks. Improved 6-minute walk test and fatigue scores
• Heart Failure (2019): 0.25mg/kg/hr IV infusion reduced cardiac injury markers in heart failure patients
• Barth Syndrome Phase III (2021): 40mg daily for 48 weeks. Trends toward cardiac improvement, though primary endpoint was not met

Dosing

SS-31 is light-sensitive. Store in amber vials, refrigerated. Use within 30 days of reconstitution. Calculate your dose

MOTS-c: The Metabolic Sensor

MOTS-c is fundamentally different from SS-31. It’s not synthetic. It’s encoded by your own mitochondrial DNA, specifically the 12S rRNA gene (MT-RNR1). Your body makes it. Levels decline with age.

The mechanism is indirect but powerful. MOTS-c inhibits the folate cycle, which leads to accumulation of AICAR, which activates AMPK. AMPK is sometimes called the “master metabolic switch.” It triggers glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. A 2018 study (Kim et al., Cell Metabolism) showed MOTS-c translocates to the cell nucleus within 30 minutes of metabolic stress, where it binds stress-response transcription factors NRF2 and ATF1.

The 2015 landmark paper by Lee et al. in Cell Metabolism showed MOTS-c prevented obesity and improved insulin sensitivity by approximately 30% in high-fat diet mice. A 2021 Nature Communications study showed it enhanced physical performance across age groups, with exercise inducing an 11.9-fold increase in skeletal muscle MOTS-c. A 2022 study (Hyatt et al.) found a single dose improved running time by 12% and distance by 15%.

The latest research from 2025 (Nature) demonstrates MOTS-c prevents pancreatic islet cell senescence and delays diabetes onset. This is new territory for a peptide that was initially studied purely for metabolic effects.